Finance Roundup: WHOI, Sonian, 5AM Ventures

In today’s Finance Roundup, 5AM raises a fund, Rapid Micro Biosystems raises a round, and Sonian raises a tranche.

5AM Ventures raises $159M life sciences fund

Life sciences-focused venture capital firm 5AM Ventures has raised $159 million from 34 investors in its third fund, according to a filing with the U.S. Securities and Exchange Commission.

Rapid Micro Biosystems raises $18.6M

Rapid Micro Biosystems Inc., a Bedford-based microbial contamination detection firm, has landed an investment of $18.6 million in a Series A round from Kleiner Perkins Caufield & Byers, TVM Capital, Quaker BioVentures and VIMAC Milestone Medica Fund.

Marine Biological Lab, Cape Cod RTDC partner in R&D

The Marine Biological Laboratory has partnered with the Regional Technology Development Corp. of Cape Cod to commercialize biological discovery technologies coming out of MBL research projects.

Morgenthaler leads $20M VC round for Calif. med device firm

Relievant Medsystems Inc., a California-based medical devices company, has raised $20 million in venture funding from investors led by Morgenthaler Ventures, which has an office in Boston.

WHOI names Winslow as CFO

Winslow joins WHOI having previously served as CFO of University of Wisconsin-Madison’s research and technology transfer institution, the Wisconsin Alumni Research Foundation, where he was responsible for co-managing the organization’s $1.5 billion portfolio.

Email software firm Sonian raises $4M tranche

Prism Ventureworks is one of two investors in the Dedham-based company, with partner Will Kohler taking a board seat. Kohler and Sonian founder and CTO Greg Arnette confirmed the amount of the funding but declined to name the second syndicated investor, saying that information will become available once the deal closes later this month.

Posted by Brendan Lynch

Tags: , , ,

Leave a Reply

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.